| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Heart disease and stroke statistics--2012 update: a report from the American Heart Association.
|
Circulation
|
2011
|
31.98
|
|
2
|
Heart disease and stroke statistics--2011 update: a report from the American Heart Association.
|
Circulation
|
2010
|
30.07
|
|
3
|
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
|
J Am Coll Cardiol
|
2013
|
17.18
|
|
4
|
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
|
Circulation
|
2013
|
16.52
|
|
5
|
Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association.
|
Circulation
|
2011
|
14.00
|
|
6
|
Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond.
|
Circulation
|
2010
|
13.28
|
|
7
|
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
|
Circulation
|
2013
|
10.24
|
|
8
|
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
|
J Am Coll Cardiol
|
2013
|
8.90
|
|
9
|
Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association.
|
Circulation
|
2012
|
6.24
|
|
10
|
Lifetime risks of cardiovascular disease.
|
N Engl J Med
|
2012
|
5.95
|
|
11
|
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association.
|
Circulation
|
2011
|
5.26
|
|
12
|
Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring.
|
JAMA
|
2004
|
4.85
|
|
13
|
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation.
|
Circulation
|
2011
|
4.65
|
|
14
|
Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial.
|
Eur Heart J
|
2005
|
4.37
|
|
15
|
The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.
|
Am J Cardiol
|
2005
|
3.85
|
|
16
|
Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop.
|
Circulation
|
2009
|
3.50
|
|
17
|
Prevalence and progression of subclinical atherosclerosis in younger adults with low short-term but high lifetime estimated risk for cardiovascular disease: the coronary artery risk development in young adults study and multi-ethnic study of atherosclerosis.
|
Circulation
|
2009
|
3.37
|
|
18
|
Multiple behavior changes in diet and activity: a randomized controlled trial using mobile technology.
|
Arch Intern Med
|
2012
|
3.35
|
|
19
|
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association.
|
J Am Coll Cardiol
|
2011
|
2.89
|
|
20
|
Accuracy of offspring reports of parental cardiovascular disease history: the Framingham Offspring Study.
|
Ann Intern Med
|
2004
|
2.74
|
|
21
|
Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study.
|
J Am Coll Cardiol
|
2008
|
2.74
|
|
22
|
Who exceeds ATP-III risk thresholds? Systematic examination of the effect of varying age and risk factor levels in the ATP-III risk assessment tool.
|
Prev Med
|
2008
|
2.66
|
|
23
|
Cardiovascular health behavior and health factor changes (1988-2008) and projections to 2020: results from the National Health and Nutrition Examination Surveys.
|
Circulation
|
2012
|
2.59
|
|
24
|
Status of cardiovascular health in US adults: prevalence estimates from the National Health and Nutrition Examination Surveys (NHANES) 2003-2008.
|
Circulation
|
2011
|
2.54
|
|
25
|
AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association.
|
J Am Coll Cardiol
|
2011
|
2.45
|
|
26
|
Favorable cardiovascular risk profile in young women and long-term risk of cardiovascular and all-cause mortality.
|
JAMA
|
2004
|
2.45
|
|
27
|
Healthy lifestyle through young adulthood and the presence of low cardiovascular disease risk profile in middle age: the Coronary Artery Risk Development in (Young) Adults (CARDIA) study.
|
Circulation
|
2012
|
2.40
|
|
28
|
Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
|
J Am Coll Cardiol
|
2005
|
2.34
|
|
29
|
Multimarker prediction of coronary heart disease risk: the Women's Health Initiative.
|
J Am Coll Cardiol
|
2010
|
2.34
|
|
30
|
Systematic examination of the updated Framingham heart study general cardiovascular risk profile.
|
Circulation
|
2009
|
2.20
|
|
31
|
Distribution of 10-year and lifetime predicted risks for cardiovascular disease in US adults: findings from the National Health and Nutrition Examination Survey 2003 to 2006.
|
Circ Cardiovasc Qual Outcomes
|
2009
|
2.17
|
|
32
|
Racial differences in risks for first cardiovascular events and noncardiovascular death: the Atherosclerosis Risk in Communities study, the Cardiovascular Health Study, and the Multi-Ethnic Study of Atherosclerosis.
|
Circulation
|
2012
|
1.99
|
|
33
|
Lifetime risks for cardiovascular disease mortality by cardiorespiratory fitness levels measured at ages 45, 55, and 65 years in men. The Cooper Center Longitudinal Study.
|
J Am Coll Cardiol
|
2011
|
1.95
|
|
34
|
Predictive utility of pulse pressure and other blood pressure measures for cardiovascular outcomes.
|
Hypertension
|
2007
|
1.93
|
|
35
|
Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study.
|
J Am Coll Cardiol
|
2007
|
1.92
|
|
36
|
Ethnic differences in C-reactive protein concentrations.
|
Clin Chem
|
2008
|
1.87
|
|
37
|
Association of neighborhood characteristics with cardiovascular health in the multi-ethnic study of atherosclerosis.
|
Circ Cardiovasc Qual Outcomes
|
2014
|
1.65
|
|
38
|
Noninvasive evaluation of coronary distensibility in older adults: a feasibility study with MR angiography.
|
Radiology
|
2011
|
1.60
|
|
39
|
Lifetime risk and years lived free of total cardiovascular disease.
|
JAMA
|
2012
|
1.57
|
|
40
|
AHA/ACCF [corrected] 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association task force on performance measures (writing committee to develop performance measures for primary prevention of cardiovascular disease): developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association: endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research.
|
Circulation
|
2009
|
1.54
|
|
41
|
Yield of screening for coronary artery calcium in early middle-age adults based on the 10-year Framingham Risk Score: the CARDIA study.
|
JACC Cardiovasc Imaging
|
2012
|
1.52
|
|
42
|
Natural history of the early repolarization pattern in a biracial cohort: CARDIA (Coronary Artery Risk Development in Young Adults) Study.
|
J Am Coll Cardiol
|
2013
|
1.50
|
|
43
|
Biomarkers for coronary heart disease clinical risk prediction: a critical appraisal. Counterpoint.
|
Prev Cardiol
|
2010
|
1.49
|
|
44
|
Effect of intensive lipid lowering, with or without antioxidant vitamins, compared with moderate lipid lowering on myocardial ischemia in patients with stable coronary artery disease: the Vascular Basis for the Treatment of Myocardial Ischemia Study.
|
Circulation
|
2005
|
1.49
|
|
45
|
Major and minor ECG abnormalities in asymptomatic women and risk of cardiovascular events and mortality.
|
JAMA
|
2007
|
1.47
|
|
46
|
Treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: synopsis of the 2013 American College of Cardiology/American Heart Association cholesterol guideline.
|
Ann Intern Med
|
2014
|
1.47
|
|
47
|
A propensity-matched study of the effect of diabetes on the natural history of heart failure: variations by sex and age.
|
Heart
|
2007
|
1.46
|
|
48
|
Competing cardiovascular outcomes associated with subclinical atherosclerosis (from the Multi-Ethnic Study of Atherosclerosis).
|
Am J Cardiol
|
2013
|
1.45
|
|
49
|
Framingham risk score and prediction of coronary heart disease death in young men.
|
Am Heart J
|
2007
|
1.42
|
|
50
|
Cardiovascular health through young adulthood and cognitive functioning in midlife.
|
Ann Neurol
|
2013
|
1.42
|
|
51
|
Altered blood pressure progression in the community and its relation to clinical events.
|
Arch Intern Med
|
2008
|
1.38
|
|
52
|
Association between hyperuricemia and incident heart failure among older adults: a propensity-matched study.
|
Int J Cardiol
|
2009
|
1.38
|
|
53
|
Predicting cardiovascular risk: so what do we do now?
|
Arch Intern Med
|
2006
|
1.36
|
|
54
|
Inflammatory, lipid, thrombotic, and genetic markers of coronary heart disease risk in the women's health initiative trials of hormone therapy.
|
Arch Intern Med
|
2008
|
1.34
|
|
55
|
Increased complication rates of cardiac rhythm management devices in ESRD patients.
|
Am J Kidney Dis
|
2007
|
1.34
|
|
56
|
Comparison of risk factors for cardiovascular mortality in black and white adults.
|
Arch Intern Med
|
2006
|
1.30
|
|
57
|
Status of cardiovascular health in US adolescents: prevalence estimates from the National Health and Nutrition Examination Surveys (NHANES) 2005-2010.
|
Circulation
|
2013
|
1.24
|
|
58
|
Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.
|
Am Heart J
|
2005
|
1.24
|
|
59
|
2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents.
|
J Am Coll Cardiol
|
2016
|
1.24
|
|
60
|
Comparison of long-term mortality across the spectrum of acute coronary syndromes.
|
Am Heart J
|
2006
|
1.21
|
|
61
|
Electronic health record-based cardiac risk assessment and identification of unmet preventive needs.
|
Med Care
|
2009
|
1.21
|
|
62
|
Lifetime risk for heart failure among white and black Americans: cardiovascular lifetime risk pooling project.
|
J Am Coll Cardiol
|
2013
|
1.21
|
|
63
|
Quantifying options for reducing coronary heart disease mortality by 2020.
|
Circulation
|
2013
|
1.20
|
|
64
|
Prevalence of electrocardiographic abnormalities in a middle-aged, biracial population: Coronary Artery Risk Development in Young Adults study.
|
J Electrocardiol
|
2010
|
1.20
|
|
65
|
Impact of blood pressure and blood pressure change during middle age on the remaining lifetime risk for cardiovascular disease: the cardiovascular lifetime risk pooling project.
|
Circulation
|
2011
|
1.20
|
|
66
|
Effects of exercise training and metformin on body composition and cardiovascular indices in HIV-infected patients.
|
AIDS
|
2004
|
1.18
|
|
67
|
A comparison of death certificate out-of-hospital coronary heart disease death with physician-adjudicated sudden cardiac death.
|
Am J Cardiol
|
2005
|
1.16
|
|
68
|
Potential use of 10-year and lifetime coronary risk information for preventive cardiology prescribing decisions: a primary care physician survey.
|
Arch Intern Med
|
2010
|
1.16
|
|
69
|
ACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease) developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association: endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research.
|
J Am Coll Cardiol
|
2009
|
1.16
|
|
70
|
Distribution of coronary artery calcium scores by Framingham 10-year risk strata in the MESA (Multi-Ethnic Study of Atherosclerosis) potential implications for coronary risk assessment.
|
J Am Coll Cardiol
|
2011
|
1.15
|
|
71
|
Association of traditional risk factors with cardiovascular death across 0 to 10, 10 to 20, and >20 years follow-up in men and women.
|
Am J Cardiol
|
2008
|
1.13
|
|
72
|
Electronic health record-based patient identification and individualized mailed outreach for primary cardiovascular disease prevention: a cluster randomized trial.
|
J Gen Intern Med
|
2012
|
1.13
|
|
73
|
Development and validation of a coronary risk prediction model for older U.S. and European persons in the Cardiovascular Health Study and the Rotterdam Study.
|
Ann Intern Med
|
2012
|
1.10
|
|
74
|
National Cholesterol Education Program risk assessment and potential for risk misclassification.
|
Prev Med
|
2006
|
1.09
|
|
75
|
Prevalence, prognosis, and implications of isolated minor nonspecific ST-segment and T-wave abnormalities in older adults: Cardiovascular Health Study.
|
Circulation
|
2008
|
1.09
|
|
76
|
Treatment of Blood Cholesterol to Reduce Risk for Atherosclerotic Cardiovascular Disease.
|
Ann Intern Med
|
2016
|
1.08
|
|
77
|
Distribution of 10-year and lifetime predicted risk for cardiovascular disease in the Indian Sentinel Surveillance Study population (cross-sectional survey results).
|
BMJ Open
|
2011
|
1.07
|
|
78
|
Calibration and Discrimination Among Multiple Cardiovascular Risk Scores in a Modern Multiethnic Cohort.
|
Ann Intern Med
|
2015
|
1.07
|
|
79
|
Multiple biomarker panels for cardiovascular risk assessment.
|
N Engl J Med
|
2008
|
1.06
|
|
80
|
Large-scale candidate gene analysis in whites and African Americans identifies IL6R polymorphism in relation to atrial fibrillation: the National Heart, Lung, and Blood Institute's Candidate Gene Association Resource (CARe) project.
|
Circ Cardiovasc Genet
|
2011
|
1.06
|
|
81
|
Burden of cardiovascular risk factors, subclinical atherosclerosis, and incident cardiovascular events across dimensions of religiosity: The multi-ethnic study of atherosclerosis.
|
Circulation
|
2010
|
1.06
|
|
82
|
Dietary fish intake and incident atrial fibrillation (from the Women's Health Initiative).
|
Am J Cardiol
|
2010
|
1.05
|
|
83
|
The role of biomarkers and genetics in peripheral arterial disease.
|
J Am Coll Cardiol
|
2009
|
1.05
|
|
84
|
Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department.
|
Arch Intern Med
|
2006
|
1.05
|
|
85
|
Reference ranges of PR duration and P-wave indices in individuals free of cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA).
|
J Electrocardiol
|
2013
|
1.04
|
|
86
|
Longitudinal association of PCSK9 sequence variations with low-density lipoprotein cholesterol levels: the Coronary Artery Risk Development in Young Adults Study.
|
Circ Cardiovasc Genet
|
2009
|
1.04
|
|
87
|
Preventing cardiovascular disease in the 21st century: therapeutic and preventive implications of current evidence.
|
Am J Cardiovasc Drugs
|
2006
|
1.03
|
|
88
|
Carotid intima-media thickness is associated with premature parental coronary heart disease: the Framingham Heart Study.
|
Circulation
|
2003
|
1.02
|
|
89
|
Clinical significance of minor nonspecific ST-segment and T-wave abnormalities in asymptomatic subjects: a systematic review.
|
Cardiol Rev
|
2007
|
1.01
|
|
90
|
Prediction of coronary artery calcium progression in individuals with low Framingham Risk Score: the Multi-Ethnic Study of Atherosclerosis.
|
JACC Cardiovasc Imaging
|
2012
|
0.98
|
|
91
|
Care concordant with guidelines predicts decreased long-term mortality in patients with unstable angina pectoris and non-ST-elevation myocardial infarction.
|
Am J Cardiol
|
2004
|
0.97
|
|
92
|
Association of QRS duration with left ventricular structure and function and risk of heart failure in middle-aged and older adults: the Multi-Ethnic Study of Atherosclerosis (MESA).
|
Eur J Heart Fail
|
2012
|
0.97
|
|
93
|
Systolic blood pressure and incident heart failure in the elderly. The Cardiovascular Health Study and the Health, Ageing and Body Composition Study.
|
Heart
|
2011
|
0.96
|
|
94
|
Competing cardiovascular outcomes associated with electrocardiographic left ventricular hypertrophy: the Atherosclerosis Risk in Communities Study.
|
Heart
|
2011
|
0.94
|
|
95
|
Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea.
|
Arch Intern Med
|
2007
|
0.94
|
|
96
|
Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) study.
|
J Card Fail
|
2007
|
0.94
|
|
97
|
The association of Framingham and Reynolds risk scores with incidence and progression of coronary artery calcification in MESA (Multi-Ethnic Study of Atherosclerosis).
|
J Am Coll Cardiol
|
2011
|
0.94
|
|
98
|
Optimal cardiovascular prevention strategies for the 21st century.
|
JAMA
|
2010
|
0.93
|
|
99
|
Importance of biomarkers for long-term mortality prediction in acutely dyspneic patients.
|
Clin Chem
|
2010
|
0.93
|
|
100
|
Activated TLR signaling in atherosclerosis among women with lower Framingham risk score: the multi-ethnic study of atherosclerosis.
|
PLoS One
|
2011
|
0.92
|
|
101
|
Improving the cardiovascular health of the US population.
|
JAMA
|
2012
|
0.92
|
|
102
|
Coronary heart disease risks associated with high levels of HDL cholesterol.
|
J Am Heart Assoc
|
2014
|
0.92
|
|
103
|
Lifetime risk for cancer death by sex and smoking status: the lifetime risk pooling project.
|
Cancer Causes Control
|
2012
|
0.91
|
|
104
|
Impact of inflammatory biomarkers on relation of high density lipoprotein-cholesterol with incident coronary heart disease: cardiovascular Health Study.
|
Atherosclerosis
|
2013
|
0.91
|
|
105
|
Chicago Healthy Aging Study: objectives and design.
|
Am J Epidemiol
|
2013
|
0.90
|
|
106
|
Elevated serum creatinine is associated with 1-year mortality after acute myocardial infarction.
|
Am Heart J
|
2002
|
0.90
|
|
107
|
Potential quantitative magnetic resonance imaging biomarkers of coronary remodeling in older hypertensive patients.
|
Arterioscler Thromb Vasc Biol
|
2012
|
0.90
|
|
108
|
Factors associated with development of prolonged QRS duration over 20 years in healthy young adults: the Coronary Artery Risk Development in Young Adults study.
|
J Electrocardiol
|
2011
|
0.89
|
|
109
|
C-reactive protein in the prediction of cardiovascular events.
|
N Engl J Med
|
2003
|
0.89
|
|
110
|
Relation of body mass index to late survival after valvular heart surgery.
|
Am J Cardiol
|
2012
|
0.89
|
|
111
|
Gene expression variation between African Americans and whites is associated with coronary artery calcification: the multiethnic study of atherosclerosis.
|
Physiol Genomics
|
2011
|
0.88
|
|
112
|
Implications of changing national cholesterol education program goals for the treatment and control of hypercholesterolemia.
|
J Gen Intern Med
|
2005
|
0.88
|
|
113
|
Usefulness of the TIMI Risk Index in predicting short- and long-term mortality in patients with acute coronary syndromes.
|
Am J Cardiol
|
2005
|
0.87
|
|
114
|
Algorithms for assessing cardiovascular risk in women.
|
JAMA
|
2007
|
0.87
|
|
115
|
Heart failure in women: epidemiology, biology and treatment.
|
Womens Health (Lond Engl)
|
2009
|
0.86
|
|
116
|
Prospective relationship of low cardiovascular risk factor profile at younger ages to ankle-brachial index: 39-year follow-up--the Chicago Healthy Aging Study.
|
J Am Heart Assoc
|
2012
|
0.86
|
|
117
|
Comparison of effect of intensive lipid lowering with atorvastatin to less intensive lowering with lovastatin on C-reactive protein in patients with stable angina pectoris and inducible myocardial ischemia.
|
Am J Cardiol
|
2002
|
0.86
|
|
118
|
Trends in vascular risk factor treatment and control in US stroke survivors: the National Health and Nutrition Examination Surveys (1999-2010).
|
Circ Cardiovasc Qual Outcomes
|
2013
|
0.86
|
|
119
|
Prevalence, prospective risk markers, and prognosis associated with the presence of left ventricular diastolic dysfunction in young adults: the coronary artery risk development in young adults study.
|
Am J Epidemiol
|
2012
|
0.85
|
|
120
|
Healthy lifestyle interventions to combat noncommunicable disease-a novel nonhierarchical connectivity model for key stakeholders: a policy statement from the American Heart Association, European Society of Cardiology, European Association for Cardiovascular Prevention and Rehabilitation, and American College of Preventive Medicine.
|
Eur Heart J
|
2015
|
0.84
|
|
121
|
Incident obesity and cardiovascular risk factors between young adulthood and middle age by religious involvement: the Coronary Artery Risk Development in Young Adults (CARDIA) study.
|
Prev Med
|
2011
|
0.84
|
|
122
|
Associations of noninvasive measures of arterial compliance and ankle-brachial index: the Multi-Ethnic Study of Atherosclerosis (MESA).
|
Am J Hypertens
|
2012
|
0.84
|
|
123
|
Effects of respiratory motion on coronary wall MR imaging: a quantitative study of older adults.
|
Int J Cardiovasc Imaging
|
2013
|
0.84
|
|
124
|
Education, income, and incident heart failure in post-menopausal women: the Women's Health Initiative Hormone Therapy Trials.
|
J Am Coll Cardiol
|
2011
|
0.83
|
|
125
|
Epidemiology of hypertension in the elderly.
|
Clin Geriatr Med
|
2009
|
0.82
|
|
126
|
High early cardiovascular mortality after liver transplantation.
|
Liver Transpl
|
2014
|
0.82
|
|
127
|
Minor isolated Q waves and cardiovascular events in the MESA study.
|
Am J Med
|
2013
|
0.82
|
|
128
|
Factors associated with presence and extent of coronary calcium in those predicted to be at low risk according to Framingham risk score (from the Multi-Ethnic Study of Atherosclerosis).
|
Am J Cardiol
|
2011
|
0.82
|
|
129
|
Adding a life-course perspective to cardiovascular-risk communication.
|
Nat Rev Cardiol
|
2013
|
0.82
|
|
130
|
Lowering LDL cholesterol is good, but how and in whom?
|
N Engl J Med
|
2015
|
0.82
|
|
131
|
Reference values of right ventricular end-diastolic area defined by ethnicity and gender in a young adult population: the CARDIA study.
|
Echocardiography
|
2011
|
0.82
|
|
132
|
Association of number of live births with left ventricular structure and function. The Multi-Ethnic Study of Atherosclerosis (MESA).
|
Am Heart J
|
2012
|
0.81
|
|
133
|
Association of isolated minor non-specific ST-segment and T-wave abnormalities with subclinical atherosclerosis in a middle-aged, biracial population: Coronary Artery Risk Development in Young Adults (CARDIA) study.
|
Eur J Prev Cardiol
|
2012
|
0.81
|
|
134
|
Prognostic value of frontal QRS-T angle in patients without clinical evidence of cardiovascular disease (from the Multi-Ethnic Study of Atherosclerosis).
|
Am J Cardiol
|
2013
|
0.81
|
|
135
|
Association of Sleep Apnea and Snoring With Incident Atrial Fibrillation in the Multi-Ethnic Study of Atherosclerosis.
|
Am J Epidemiol
|
2015
|
0.80
|
|
136
|
C-reactive protein level and the incidence of eligibility for statin therapy: the multi-ethnic study of atherosclerosis.
|
Clin Cardiol
|
2012
|
0.80
|
|
137
|
Association of annular calcification and aortic valve sclerosis with brain findings on magnetic resonance imaging in community dwelling older adults: the cardiovascular health study.
|
J Am Coll Cardiol
|
2011
|
0.80
|
|
138
|
Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study.
|
Am Heart J
|
2007
|
0.80
|
|
139
|
Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool.
|
J Am Coll Cardiol
|
2016
|
0.80
|
|
140
|
Comparing costs associated with risk stratification rules for t-year survival.
|
Biostatistics
|
2011
|
0.79
|
|
141
|
White blood cell count in young adulthood and coronary artery calcification in early middle age: coronary artery risk development in young adults (CARDIA) study.
|
Eur J Epidemiol
|
2013
|
0.78
|
|
142
|
Need for Better Methodology in Assessing Pooled Cohort Equations.
|
J Am Coll Cardiol
|
2017
|
0.77
|
|
143
|
Social avoidance and long-term risk for cardiovascular disease death in healthy men: the Western Electric study.
|
Ann Epidemiol
|
2007
|
0.77
|
|
144
|
Association of electrocardiographically determined left ventricular mass with incident diabetes, 1985-1986 to 2010-2011: Coronary Artery Risk Development in Young Adults (CARDIA) study.
|
Diabetes Care
|
2012
|
0.77
|
|
145
|
Associations between a parental history of premature cardiovascular disease and coronary artery calcium and carotid intima-media thickness: the Coronary Artery Risk Development In Young Adults (CARDIA) study.
|
Eur J Prev Cardiol
|
2012
|
0.77
|
|
146
|
Coronary artery calcium testing: dos and don'ts.
|
Cardiol Clin
|
2011
|
0.77
|
|
147
|
A convenient tool to profile patients for generalized cardiovascular disease risk in primary care.
|
Am J Cardiol
|
2009
|
0.77
|
|
148
|
Inflammatory markers, amino-terminal pro-brain natriuretic peptide, and mortality risk in dyspneic patients.
|
Am J Clin Pathol
|
2008
|
0.77
|
|
149
|
The association of heart rate recovery immediately after exercise with coronary artery calcium: the coronary artery risk development in young adults study.
|
Clin Auton Res
|
2007
|
0.77
|
|
150
|
Are novel serum biomarkers informative?
|
Med Clin North Am
|
2012
|
0.77
|
|
151
|
Healthy Lifestyle Interventions to Combat Noncommunicable Disease—A Novel Nonhierarchical Connectivity Model for Key Stakeholders: A Policy Statement From the American Heart Association, European Society of Cardiology, European Association for Cardiovascular Prevention and Rehabilitation, and American College of Preventive Medicine.
|
Mayo Clin Proc
|
2015
|
0.76
|
|
152
|
T1 contrast in the myocardium and blood pool: a quantitative assessment of gadopentetate dimeglumine and gadofosveset trisodium at 1.5 and 3 T.
|
Invest Radiol
|
2014
|
0.76
|
|
153
|
Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool: A Special Report From the American Heart Association and American College of Cardiology.
|
Circulation
|
2016
|
0.76
|
|
154
|
Letter regarding article by Ridker et al, "Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?".
|
Circulation
|
2004
|
0.76
|
|
155
|
The compensation for asynchronous cardiac quiescence in coronary wall MR imaging.
|
Int J Cardiovasc Imaging
|
2013
|
0.75
|
|
156
|
C-reactive protein levels and outcomes after statin therapy.
|
N Engl J Med
|
2005
|
0.75
|
|
157
|
The role of latency period in quality management for free-breathing coronary wall MRI.
|
Int J Cardiovasc Imaging
|
2015
|
0.75
|
|
158
|
Do statins reduce the risk of myocardial infarction in patients with heart failure? A pooled individual-level reanalysis of CORONA and GISSI-HF.
|
Eur J Heart Fail
|
2015
|
0.75
|
|
159
|
Problems associated with screening for asymptomatic cardiac transplant rejection.
|
J Heart Lung Transplant
|
2007
|
0.75
|
|
160
|
HIV-Related Myocardial Vulnerability to Infarction and Coronary Artery Disease.
|
J Am Coll Cardiol
|
2016
|
0.75
|
|
161
|
Association of Traditional Cardiovascular Risk Factors With Development of Major and Minor Electrocardiographic Abnormalities: A Systematic Review.
|
Cardiol Rev
|
2016
|
0.75
|
|
162
|
Reply: Clinical Significance and Potential Mechanism of Discordance Between Apolipoprotein B and LDL-Cholesterol.
|
J Am Coll Cardiol
|
2016
|
0.75
|
|
163
|
Macrophage inflammation and cardiovascular disease in HIV: Mechanistic Insights and Future Directions.
|
J Infect Dis
|
2017
|
0.75
|
|
164
|
2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways.
|
J Am Coll Cardiol
|
2017
|
0.75
|
|
165
|
Vascular basis for the treatment of myocardial ischemia study: trial design and baseline characteristics.
|
Am Heart J
|
2004
|
0.75
|